4 results match your criteria: "The Third Hospital of Jinzhou Medical University[Affiliation]"
Front Neurosci
August 2022
Respiratory Medicine, The Third Hospital of Jinzhou Medical University, Jinzhou, China.
Background: OSA is an independent risk factor for several systemic diseases. Compared with mild OSA, patients with moderate-to-severe OSA have more severe impairment in the function of all organs of the body. Due to the current limited medical condition, not every patient can be diagnosed and treated in time.
View Article and Find Full Text PDFUrology
December 2021
Department of Urology, the Third Hospital of Jinzhou Medical University, Jinzhou Medical University, Jinzhou, China; Department of Urology, the Fourth Medical Center of PLA General Hospital, Beijing, China. Electronic address:
Objective: To clarify the effects of cellular self-aggregation of adipose-derived stem cells (ADSCs) on erectile function (EF).
Methods: A model of neurogenic erectile dysfunction was performed using bilateral cavernous nerve crush injury in rats. ADSCs suspensions (1 × 10/0.
Biol Trace Elem Res
January 2022
Department of Orthopedics, The First Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, Liaoning, China.
The incidence of type 2 diabetic osteoporosis (T2DOP), which seriously threatens elderly people's health, is rapidly increasing in recent years. However, the specific mechanism of the T2DOP is still unclear. Studies have shown the relationship between iron overload and T2DOP.
View Article and Find Full Text PDFOxid Med Cell Longev
September 2021
Department of Orthopedics, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Ferroptosis is recently identified, an iron- and reactive oxygen species- (ROS-) dependent form of regulated cell death. This study was designed to determine the existence of ferroptosis in the pathogenesis of type 2 diabetic osteoporosis and confirm that melatonin can inhibit the ferroptosis of osteoblasts through activating Nrf2/HO-1 signaling pathway to improve bone microstructure and . We treated MC3T3-E1 cells with different concentrations of melatonin (1, 10, or 100 M) and exposed them to high glucose (25.
View Article and Find Full Text PDF